Acumen Pharmaceuticals, Inc. (ABOS) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts ABOS Hot Sheet
Join SI Premium – FREE
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q1 EPS of ($0.48), $0.03 better than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Bending Spoons (BSP) PT Raised to $50 at Benchmark on Inaugural Earnings, Revenue Beat
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
